about
Human angiogenin is rapidly translocated to the nucleus of human umbilical vein endothelial cells and binds to DNASuppression of uPA and uPAR attenuates angiogenin mediated angiogenesis in endothelial and glioblastoma cell linesAngiogenin: a review of the pathophysiology and potential clinical applications.A neuroprotective role for angiogenin in models of Parkinson's diseaseAngiogenin-mediated ribosomal RNA transcription as a molecular target for treatment of head and neck squamous cell carcinoma.Angiogenin stimulates ribosomal RNA transcription by epigenetic activation of the ribosomal DNA promoterCompartmentalized, functional role of angiogenin during spotted fever group rickettsia-induced endothelial barrier dysfunction: evidence of possible mediation by host tRNA-derived small noncoding RNAs.Identification of estrogen receptor-related receptor gamma as a direct transcriptional target of angiogenin.Angiogenin secretion from hepatoma cells activates hepatic stellate cells to amplify a self-sustained cycle promoting liver cancer.Angiogenin promotes U87MG cell proliferation by activating NF-κB signaling pathway and downregulating its binding partner FHL3A therapeutic target for prostate cancer based on angiogenin-stimulated angiogenesis and cancer cell proliferationAngiogenin as a molecular target for the treatment of prostate cancer.Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen and angiogenin interact with common host proteins, including annexin A2, which is essential for survival of latently infected cells.Neamine is preferential as an anti-prostate cancer reagent by inhibiting cell proliferation and angiogenesis, with lower toxicity than cis-platinum.Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen interacts with multifunctional angiogenin to utilize its antiapoptotic functions.Growth factors in the nucleolus?Mechanism and Function of Angiogenin in Prostate Cancer.Ribonuclease 5 facilitates corneal endothelial wound healing via activation of PI3-kinase/Akt pathwayNeamine induces neuroprotection after acute ischemic stroke in type one diabetic ratsThe Role of Vascular Endothelial Growth Factor in Small-airway Remodelling in a Rat Model of Chronic Obstructive Pulmonary Disease.The chicken chorioallantoic membrane model in biology, medicine and bioengineeringNeamine inhibits oral cancer progression by suppressing angiogenin-mediated angiogenesis and cancer cell proliferationUltrahigh dose gentamicin alters inflammation and angiogenesis in vivo and in vitro.Neamine inhibits growth of pancreatic cancer cells in vitro and in vivo.The Chick Embryo Chorioallantoic Membrane as an In Vivo Assay to Study Antiangiogenesis.Kaposi's sarcoma-associated herpesvirus-positive primary effusion lymphoma tumor formation in NOD/SCID mice is inhibited by neomycin and neamine blocking angiogenin's nuclear translocation.Kaposi's sarcoma-associated herpesvirus-induced angiogenin plays roles in latency via the phospholipase C gamma pathway: blocking angiogenin inhibits latent gene expression and induces the lytic cycle.Involvement of calcium/calmodulin signaling in cercosporin toxin biosynthesis by Cercospora nicotianae.Neamine inhibits prostate cancer growth by suppressing angiogenin-mediated rRNA transcriptionKaposi's sarcoma-associated herpesvirus upregulates angiogenin during infection of human dermal microvascular endothelial cells, which induces 45S rRNA synthesis, antiapoptosis, cell proliferation, migration, and angiogenesisAngiogenin-stimulated rRNA transcription is essential for initiation and survival of AKT-induced prostate intraepithelial neoplasia.Angiogenin functionally interacts with p53 and regulates p53-mediated apoptosis and cell survival.Angiogenin-mediated rRNA transcription in cancer and neurodegeneration.Evidence for novel action at the cell binding site of human Angiogenin revealed by heteronuclear NMR spectroscopy, in silico and in vivo studies.Glioma cell-associated sustained activation of the transcription factor, nuclear factor-kappa B, was inhibited by neomycin.Endothelial Progenitor Cell Secretome and Oligovascular Repair in a Mouse Model of Prolonged Cerebral Hypoperfusion.Mutational biosynthesis of neomycin analogs by a mutant of neomycin-producing Streptomyces fradiae.Pharmacokinetics of neamine in rats and anti-cervical cancer activity in vitro and in vivo.
P2860
Q22011166-7EE43391-F221-43D1-8210-4D1376F37CFDQ33678848-2776ECBE-DBE8-4839-896A-C2D5B1EC4F54Q33999348-34B8AF00-5E4D-44F8-95E5-94EFBF3D8AC1Q34024770-444080FC-C712-40F1-AD76-E1BDF2033E33Q34101582-76871DF9-DBE6-4BB3-95F5-DAAA674547CDQ34335256-0239F687-4865-4E87-9FD6-E6864B489AE7Q34783532-D9D2ADFD-88EC-46CD-ADAA-20A4D7D68F76Q34971229-2EA7C6D9-6722-46D6-A585-27CADC4A453FQ34990566-D963D108-BB38-48D0-ABDD-8E5EAAF4A61CQ35058941-8EC7C5CF-0AA5-44D2-BF0A-356F01509F2CQ35080731-4208BFB1-1987-4916-A065-05D07DF9BF9BQ35090356-E6AA262B-8E79-4D52-A8D5-1DDB21FDD2F4Q35689577-F342B7CB-FFDF-497E-81EF-9EB99768FB42Q35803636-5B143341-528F-4AA9-B3CE-B514B9EB4BB4Q36023151-FF5C300F-38DE-4F57-96BA-1449BF380CC5Q36255609-6B40F2A8-FDF6-43DC-A29F-EC1D044D69DAQ36888285-8D41CE9D-B366-4D40-8B58-C62BCB6E7AC3Q37177040-D6A099F5-3D39-4352-9EBB-FE4744B7055AQ37467536-FD4A1C7C-0735-4873-A1A4-E2B5298CB91AQ37602044-BDBB3E78-322B-401A-9F2F-16FCB1C7944EQ38241348-32FF9FE8-77E5-44C3-9F8F-086366AB23E8Q38538634-E4D54FE0-BBB0-46A7-BCEC-088E2EE3C057Q38700586-1A46F706-B714-4A4B-8790-ACC883070188Q38797213-E19B023B-2DA5-440B-90FA-28EA3CECE027Q38974193-1F26C143-82B3-4170-884C-AE32B0D11838Q39103566-B5BC1B06-C8F3-40B4-9A56-3C0738A78F87Q39611761-DBA5FF18-0373-44DC-AD84-69D5FE56BC78Q39708515-ED1722FE-07FF-4FFB-891A-8AD9F5D343BBQ39874765-45021861-6BEB-4454-B7EB-F90D7C7F1D0EQ39892759-646EAA39-2A21-4C81-B228-80785A96FF3FQ41856878-935EF29F-FA37-4609-BBF9-309745F88BC2Q41859241-31C2847B-13B1-4440-BAAE-BE4C7D7A2D70Q41982994-ABAB8351-37ED-4EF8-B1BC-7A9AEC28BD42Q47190885-601DD108-4D51-4D2A-8835-734144E1072FQ47923671-AB63FDE2-24C3-4210-AD5A-1F84F0B0E02EQ50532130-A097611C-0842-493A-86B3-7D14397A5CB4Q52618294-D1D69E4E-FBA6-4908-B774-41739CDCB037Q53648362-191CA1E9-8369-46E8-BE96-0BCA5AB45436
P2860
description
1998 nî lūn-bûn
@nan
1998 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Neomycin inhibits angiogenin-induced angiogenesis
@ast
Neomycin inhibits angiogenin-induced angiogenesis
@en
Neomycin inhibits angiogenin-induced angiogenesis
@en-gb
Neomycin inhibits angiogenin-induced angiogenesis
@nl
type
label
Neomycin inhibits angiogenin-induced angiogenesis
@ast
Neomycin inhibits angiogenin-induced angiogenesis
@en
Neomycin inhibits angiogenin-induced angiogenesis
@en-gb
Neomycin inhibits angiogenin-induced angiogenesis
@nl
prefLabel
Neomycin inhibits angiogenin-induced angiogenesis
@ast
Neomycin inhibits angiogenin-induced angiogenesis
@en
Neomycin inhibits angiogenin-induced angiogenesis
@en-gb
Neomycin inhibits angiogenin-induced angiogenesis
@nl
P2860
P3181
P356
P1476
Neomycin inhibits angiogenin-induced angiogenesis
@en
P2093
P2860
P304
P3181
P356
10.1073/PNAS.95.17.9791
P407
P577
1998-08-18T00:00:00Z